SB0226 (CH0476)

Find a 2017 Bill:

2017 Regular Session

 

Entitled:

Biotechnology Investment Tax Credit - Qualified Maryland Biotechnology Company - Definition

Sponsored by:

Senator Manno

Status:

Approved by the Governor - Chapter 476


Synopsis:Altering the definition of "qualified Maryland biotechnology company" to extend a specified time period from a specified date that an active business may claim the biotechnology tax credit; altering the definition of "biotechnology company" to include a company that will be primarily engaged in, or within 2 months will be primarily engaged in, specified activities; providing for the revocation of a specified tax credit certificate and the recapture of the tax credit under specified circumstances; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Senators Manno, Edwards, Feldman, Hough, Kasemeyer, King, Lee, Madaleno, Peters, Serafini, Young, DeGrange, and McFadden
Additional Facts:Cross-filed with: HB0373
Introduced in a prior session as: SB1107 Session: 2016 Regular Session
Bill File Type: Regular
Effective Date(s): June 1, 2017
Committee(s):
Budget and Taxation  View Committee HearingWays and Means  View Committee Hearing
Broad Subject(s):Taxes - Income
Narrow Subject(s):Industry and Technology
Investments -see also- Securities
Medical Research
Tax Credits
Statutes:Article - Tax - General
(10-725)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


May 11, 2017 1:53 P.M.